Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Announces Closing of Webinar.net Asset Purchase (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Healthcare Cannabis
Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Teal Valley
Bullboard Posts
User Avatar Image
(1)
•••
Comment by Uberlandiaon Mar 13, 2018 4:59pm
163 Views
Post# 27709326

RE:RE:RE:RE:RE:Trevali Reports 2017 Annual Financial Results

RE:RE:RE:RE:RE:Trevali Reports 2017 Annual Financial ResultsFrom the release: Factoring in material one-time expenses related to the August 31, 2017 African asset acquisition(5) the adjusted EBITDA(1) (5) (6) is $162 million, equating to adjusted after-tax earnings(5) of $60 million or $0.11 adjusted earnings per share.(5) Read more at https://www.stockhouse.com/news/press-releases/2018/03/13/trevali-reports-2017-annual-financial-results#RAjUZsYOGzTKW8bG.99
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities